Health TrialsbyHealthPanel

Management of Seroma After Posterior Lumbar Spine Decompression

ConditionsSeromaLumbar Spine Decompression
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKafrelsheikh University

About this trial

The aim of this study is to evaluate the clinical presentation and management strategies of seroma formation following posterior lumbar spine decompression.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years.

Both sexes.

Patients undergoing elective posterior lumbar spine decompression.

Disqualifiers

History of previous lumbar spine surgery.

Active spinal infection, trauma, or malignancy.

Severe medical comorbidities that contraindicate surgery or influence wound healing (e.g., uncontrolled diabetes, immunosuppression, severe cardiovascular disease).

Patients unfit for general anesthesia.

Trial population

This retrospective study will be conducted on 50 adult patients undergoing posterior lumbar spine decompression surgery at Kafr Elsheikh University Hospitals. Approval from the Medical Sciences Ethics Committee of Kafr Elsheikh Faculty of Medicine will be taken. Written informed consent will be obtained from all participants before enrollment.

Trial design

Design model

Other

Time perspective

Retrospective

Treatments tested in this trial

  • Posterior Lumbar Spine Decompression

    Procedure/Surgery

    Patients undergoing elective posterior lumbar spine decompression.

Treatment groups

50 Participants
are divided into 1 treatment group
Group A: Study group1 intervention

Trial outcomes

Primary outcomes

1

Incidence of seroma

Incidence of seroma formation following posterior lumbar spine decompression will be recorded during hospitalization and at scheduled postoperative follow-up visits at 2 weeks, 6 weeks, 3 months, and 6 months.

Time frame
6 months postoperatively

Secondary outcomes

1

Number of aspirations required

Number of aspirations required will be recorded.

Time frame
6 months postoperatively
2

Seroma recurrence rate

Seroma recurrence rate will be recorded.

Time frame
6 months postoperatively
3

Association with patient risk factor

Association with patient risk factor will be recorded.

Time frame
6 months postoperatively

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kafrelsheikh University

Lead sponsor

Source ClinicalTrials.gov
Apply now